This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment
Hereditas Open Access 06 November 2020
-
pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
Scientific Reports Open Access 13 September 2019
-
DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia
Scientific Reports Open Access 05 July 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Harrison PJ, Weinberger DR . Mol Psychiatry 2005; 10: 40–68, (image 45).
Lin CH, Lane HY, Tsai GE . Pharmacol Biochem Behav 2012; 100: 665–677.
Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE . Arch Gen Psychiatry 2005; 62: 1196–1204.
Wang X, He G, Gu N, Yang J, Tang J, Chen Q et al. Biochem Biophys Res Commun 2004; 319: 1281–1286.
Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Proc Natl Acad Sci USA 2002; 99: 13675–13680.
Boks MP, Rietkerk T, van de Beek MH, Sommer IE, de Koning TJ, Kahn RS . Eur Neuropsychopharmacol 2007; 17: 567–572.
Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N et al. Arch Gen Psychiatry 2003; 60: 572–576.
Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H et al. Schizophr Res 2007; 90: 41–51.
Tsai GE, Lin PY . Curr Pharm Des 2010; 16: 522–537.
Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D et al. Biol Psychiatry 2004; 56: 169–176.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lin, CH., Chang, HT., Chen, YJ. et al. Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals. Mol Psychiatry 19, 636–637 (2014). https://doi.org/10.1038/mp.2013.80
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2013.80
This article is cited by
-
Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment
Hereditas (2020)
-
pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
Scientific Reports (2019)
-
DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia
Scientific Reports (2018)
-
Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients
npj Schizophrenia (2017)
-
Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment
Translational Psychiatry (2016)